Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-21

Clinical Trial Update: Abatacept in the Treatment of Uveitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating abatacept for the treatment of uveitis has completed. Results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abatacept (abatacept)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Uveitis | Phase 2 | Status: COMPLETED | Results posted: 2019-02-21